Replies to post #45141 on Predictive Technology Group Inc (PRED)

[BearNaked]

Lets start here.

NOTE 14 RELIANCE ON THIRD PARTY VALUATIONS

The Company has relied on third party valuations to determine if an impairment should be recorded and
other purposes as of March 31, 2018.

Equity Method Investments – Lifecode Genetics, Inc.
The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for marketability and minority interests, concluded the fair market value of Juneau
Biosciences, LLC to be approximately $1,320,000,000.

At March 31, 2018 the Company (including
affiliates) owned approximately 49% of Juneau (See note 7), which would value this investment at
approximately $646,800,000.

PREDICTIVE TECHNOLOGY GROUP, INC.
- 24 -

Trade Secrets – Predictive Biotech, Inc.
The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for venture capital, concluded the fair market value of trade secrets acquired with Renovo to
be approximately $501,000,000.

Other Patents and Technologies – Patents regarding Degenerative Disc Disease

Patents were acquired by the issuance of Predictive Therapeutics Class A units as described in note 6.

The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for venture capital, concluded the fair market value of such patents acquired to be
approximately $246,000,000.